Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ: SLNO )

45.32 +2.78 (+6.54%)
Streaming Delayed Price Updated: 11:48 AM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant... 
Via Benzinga
Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Dow Jones gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Shares of Soleno Therapeutics Are Booming on Tuesday
Soleno announced positive top-line results for DCCR, its lead therapy. 
Via The Motley Fool
Soleno Therapeutics Inc. (NASDAQ: SLNO) Near the Top of Equities by Percentage Gain on 9/15
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Shares of Soleno Therapeutics Dropped on Wednesday
Investors took profits a day after the clinical-stage biotech company's shares soared. 
Via The Motley Fool
Don’t Miss the Boom: 3 ETFs Set to Explode Higher
The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate. 
Via InvestorPlace
Topics ETFs
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Shares of Soleno Therapeutics (NASDAQ: SLNO) Surge Over 500% After Its DCCR Candidate Shows Promise in PWS Clinical Trials
Breakthrough Results from Study C602 Soleno Therapeutics, Inc. (NASDAQ: SLNO), a trailblazer in the biopharmaceutical industry, recently unveiled its promising 
Via Spotlight Growth
Exposures Product Safety
Soleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatment
Earlier on Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) released top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline)... 
Via Benzinga
Nasdaq Down 1.5%; Immunovant Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... 
Via Benzinga
Crude Oil Moves Higher; Cintas Earnings Top Estimates
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 while the NASDAQ fell 1.24% to 13,106.70. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Canopy Growth (CGC) Stock Up 9% Today?
Canopy Growth is in the news Tuesday after reporting results from its shareholder meeting. Approval from investors have CGC stock rising. 
Via InvestorPlace
RIVN Stock Alert: Baird Expects Rivian to Outperform in Q3
Rivian Automotive stock is getting a boost from new analysts coverage of RIVN stock. That includes a positive guidance for Q3 deliveries. 
Via InvestorPlace
Soleno Therapeutics Inc. (NASDAQ: SLNO) Near Top of Volume Charts in Tuesday Trading
Via Investor Brand Network
Why Is Soleno Therapeutics (SLNO) Stock Up 420% Today?
Soleno Therapeutics stock is taking off on Tuesday as shares of SLNO experience heavy trading alongside positive clinical trial results! 
Via InvestorPlace
Soleno Therapeutics Inc. (NASDAQ: SLNO) Sets New 52-Week High in Tuesday Session
Via Investor Brand Network
Dow Tumbles 150 Points; US House Prices Rise in July
U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.45% to 33,852.58 while the NASDAQ fell 0.74%... 
Via Benzinga
Topics Stocks
Exposures US Equities
Soleno Catapults Almost 400% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease
The company is working on a treatment for Prader Willi syndrome, a disease that causes increased hunger. 
Via Investor's Business Daily
Genetic Disorder Focused Soleno Therapeutics' Stock Is Trading 4X Today - Here's Why?
Soleno Therapeutics Inc (NASDAQ: SLNO) released top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline) Extended-Release tablets... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Oppenheimer Maintains Outperform Rating for Soleno Therapeutics: Here's What You Need To Know
Via Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga
Keep The Hunger On: Analyst Says Soleno Therapeutics' Upside Potential Much Higher Than Downside Risk
Cantor Fitzgerald has initiated coverage on Soleno Therapeutics Inc (NASDAQ: SLNO) with an Overweight rating and a  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023
Via Benzinga
7 Top Short-Squeeze Candidates to Watch in February
For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month. 
Via InvestorPlace
Kala Pharmaceuticals, Getty Images And This Bitcoin Stock Top Short Squeeze Leaderboard: 10 Short Squeeze Stocks To Watch
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.